{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:45:22Z","timestamp":1792442722025,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T00:00:00Z","timestamp":1465430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,6,9]],"date-time":"2016-06-09T00:00:00Z","timestamp":1465430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Regen Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The insulin-like growth factor Ea propeptide (IGF-1Ea) is a powerful enhancer of cardiac muscle growth and regeneration, also blocking age-related atrophy and beneficial in multiple skeletal muscle diseases. The therapeutic potential of IGF-1Ea compared with mature IGF-1 derives from its local action in the area of synthesis. We have developed an adeno-associated virus (AAV) vector for IGF-1Ea delivery to the heart to treat mice after myocardial infarction and examine the reparative effects of local IGF-1Ea production on left ventricular remodelling. A cardiotropic AAV9 vector carrying a cardiomyocyte-specific IGF-1Ea-luciferase bi-cistronic gene expression cassette (AAV9.IGF-1Ea) was administered intravenously to infarcted mice, 5\u2009h after ischemia followed by reperfusion (I\/R), as a model of myocardial infarction. Virally encoded IGF-1Ea in the heart improved global left ventricular function and remodelling, as measured by wall motion and thickness, 28 days after delivery, with higher viral titers yielding better improvement. The present study demonstrates that single intravenous AAV9-mediated IGF-1Ea Gene Therapy represents a tissue-targeted therapeutic approach to prevent the adverse remodelling after myocardial infarct.<\/jats:p>","DOI":"10.1038\/npjregenmed.2016.1","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T15:21:29Z","timestamp":1465312889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Intravenous delivery of adeno-associated virus 9-encoded IGF-1Ea propeptide improves post-infarct cardiac remodelling"],"prefix":"10.1038","volume":"1","author":[{"given":"Enrique","family":"Gallego-Colon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Villalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Tonkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J","family":"Jimenez-Borregureo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Lara-Pezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,9]]},"reference":[{"key":"BFnpjregenmed20161_CR1","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1161\/CIRCULATIONAHA.113.003961","volume":"129","author":"AS Go","year":"2014","unstructured":"Go, A. S. et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 129, e28\u2013e292 (2014).","journal-title":"Circulation"},{"key":"BFnpjregenmed20161_CR2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/CIRCHEARTFAILURE.110.957480","volume":"4","author":"DS Lee","year":"2011","unstructured":"Lee, D. S. et al. A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction. Circ. Heart Fail. 4, 36\u201343 (2011).","journal-title":"Circ. Heart Fail."},{"key":"BFnpjregenmed20161_CR3","first-page":"240","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy, C. W. et al. 2013 ACCF\/AHA guideline for the management of heart failure: A report of the american college of cardiology foundation\/american heart association task force on practice guidelines. Circulation 128, 240\u2013327 (2013).","journal-title":"Circulation"},{"key":"BFnpjregenmed20161_CR4","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.2013.281718","volume":"310","author":"S Deb","year":"2013","unstructured":"Deb, S. et al. Coronary artery bypass graft surgery versus percutaneous interventions in coronary revascularization. JAMA 310, 2086 (2013).","journal-title":"JAMA"},{"key":"BFnpjregenmed20161_CR5","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0021-9258(19)57309-4","volume":"263","author":"JL Zweier","year":"1988","unstructured":"Zweier, J. L. Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. J. Biol. Chem. 263, 1353\u20131357 (1988).","journal-title":"J. Biol. Chem."},{"key":"BFnpjregenmed20161_CR6","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1016\/S0021-9258(19)89179-2","volume":"261","author":"P Rotwein","year":"1986","unstructured":"Rotwein, P., Pollock, K. M., Didier, D. K. & Krivi, G. G. Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. J. Biol. Chem. 261, 4828\u20134832 (1986).","journal-title":"J. Biol. Chem."},{"key":"BFnpjregenmed20161_CR7","first-page":"147","volume":"4","author":"JP Frindik","year":"2010","unstructured":"Frindik, J. P. & Kemp, S. F. Managing idiopathic short stature: role of somatropin (rDNA origin) for injection. Biologics 4, 147\u2013155 (2010).","journal-title":"Biologics"},{"key":"BFnpjregenmed20161_CR8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/mp.54.5.311","volume":"54","author":"Z Laron","year":"2001","unstructured":"Laron, Z. Insulin-like growth factor 1 (IGF-1): a growth hormone. Mol. Pathol. 54, 311\u2013316 (2001).","journal-title":"Mol. Pathol."},{"key":"BFnpjregenmed20161_CR9","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1073\/pnas.81.3.935","volume":"81","author":"AJ D\u2019Ercole","year":"1984","unstructured":"D\u2019Ercole, A. J., Stiles, A. D. & Underwood, L. E. Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action. Proc. Natl Acad. Sci. USA 81, 935\u2013939 (1984).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnpjregenmed20161_CR10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/84839","volume":"27","author":"a Musar\u00f2","year":"2001","unstructured":"Musar\u00f2, a. et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat. Genet. 27, 195\u2013200 (2001).","journal-title":"Nat. Genet."},{"key":"BFnpjregenmed20161_CR11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1113\/jphysiol.2002.035832","volume":"549","author":"M Hill","year":"2003","unstructured":"Hill, M. & Goldspink, G. Expression and splicing of the insulin-like growth factor gene in rodent muscle is associated with muscle satellite (stem) cell activation following local tissue damage. J. Physiol. 549, 409\u2013418 (2003).","journal-title":"J. Physiol."},{"key":"BFnpjregenmed20161_CR12","doi-asserted-by":"crossref","first-page":"15603","DOI":"10.1073\/pnas.95.26.15603","volume":"95","author":"ER Barton-Davis","year":"1998","unstructured":"Barton-Davis, E. R., Shoturma, D. I., Musaro, A., Rosenthal, N. & Sweeney, H. L. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc. Natl Acad. Sci. USA 95, 15603\u201315607 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnpjregenmed20161_CR13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1096\/fj.06-7690com","volume":"21","author":"L Pelosi","year":"2007","unstructured":"Pelosi, L. et al. Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB J. 21, 1393\u20131402 (2007).","journal-title":"FASEB J."},{"key":"BFnpjregenmed20161_CR14","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/mt.2015.66","volume":"23","author":"J Tonkin","year":"2015","unstructured":"Tonkin, J. et al. Monocyte\/macrophage-derived IGF-1 orchestrates murine skeletal muscle regeneration and modulates autocrine polarization. Mol. Ther. 23, 1189\u20131200 (2015).","journal-title":"Mol. Ther."},{"key":"BFnpjregenmed20161_CR15","doi-asserted-by":"crossref","first-page":"484357","DOI":"10.1155\/2015\/484357","volume":"2015","author":"E Gallego-Colon","year":"2015","unstructured":"Gallego-Colon, E. et al. Cardiac-restricted IGF-1Ea overexpression reduces the early accumulation of inflammatory myeloid cells and mediates expression of extracellular matrix remodeling genes after myocardial infarction. Madiat. Inflamm. 2015, 484357 (2015).","journal-title":"Madiat. Inflamm."},{"key":"BFnpjregenmed20161_CR16","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1161\/CIRCRESAHA.107.148791","volume":"100","author":"MP Santini","year":"2007","unstructured":"Santini, M. P. et al. Enhancing repair of the mammalian heart. Circ. Res. 100, 1732\u20131740 (2007).","journal-title":"Circ. Res."},{"key":"BFnpjregenmed20161_CR17","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nm1085","volume":"10","author":"P Gregorevic","year":"2004","unstructured":"Gregorevic, P. et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat. Med. 10, 828\u2013834 (2004).","journal-title":"Nat. Med."},{"key":"BFnpjregenmed20161_CR18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt1073","volume":"23","author":"Z Wang","year":"2005","unstructured":"Wang, Z. et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat. Biotechnol. 23, 321\u2013328 (2005).","journal-title":"Nat. Biotechnol."},{"key":"BFnpjregenmed20161_CR19","first-page":"1","volume":"807","author":"MD Weitzman","year":"2011","unstructured":"Weitzman, M. D. & Linden, R. M. Adeno-associated virus biology. Methods Mol. Biol. 807, 1\u201323 (2011).","journal-title":"Methods Mol. Biol."},{"key":"BFnpjregenmed20161_CR20","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1161\/01.RES.0000237661.18885.f6","volume":"99","author":"Ca Pacak","year":"2006","unstructured":"Pacak, C. a. et al. Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ. Res. 99, e3\u2013e9 (2006).","journal-title":"Circ. Res."},{"key":"BFnpjregenmed20161_CR21","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/sj.gt.3303029","volume":"14","author":"B Bostick","year":"2007","unstructured":"Bostick, B., Ghosh, A., Yue, Y., Long, C. & Duan, D. Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration. Gene Ther. 14, 1605\u20131609 (2007).","journal-title":"Gene Ther."},{"key":"BFnpjregenmed20161_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/gt.2010.105","volume":"18","author":"K-MR Prasad","year":"2011","unstructured":"Prasad, K.-M. R., Xu, Y., Yang, Z., Acton, S. T. & French, B. A. Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution. Gene Ther. 18, 43\u201352 (2011).","journal-title":"Gene Ther."},{"key":"BFnpjregenmed20161_CR23","doi-asserted-by":"crossref","first-page":"e51152","DOI":"10.1371\/journal.pone.0051152","volume":"7","author":"MS Hede","year":"2012","unstructured":"Hede, M. S. et al. E-peptides control bioavailability of IGF-1. PLoS ONE 7, e51152 (2012).","journal-title":"PLoS ONE"},{"key":"BFnpjregenmed20161_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1474-9726.2011.00766.x","volume":"11","author":"M Vinciguerra","year":"2012","unstructured":"Vinciguerra, M. et al. mIGF-1\/JNK1\/SirT1 signaling confers protection against oxidative stress in the heart. Aging Cell 11, 139\u2013149 (2012).","journal-title":"Aging Cell"},{"key":"BFnpjregenmed20161_CR25","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.yjmcc.2009.10.008","volume":"48","author":"LW Dobrucki","year":"2010","unstructured":"Dobrucki, L. W. et al. Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging. J. Mol. Cell Cardiol. 48, 1071\u20131079 (2010).","journal-title":"J. Mol. Cell Cardiol."},{"key":"BFnpjregenmed20161_CR26","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1073\/pnas.0602877103","volume":"103","author":"ME Davis","year":"2006","unstructured":"Davis, M. E. et al. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc. Natl Acad. Sci. USA 103, 8155\u20138160 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnpjregenmed20161_CR27","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1038\/srep04257","volume":"4","author":"RS Khan","year":"2014","unstructured":"Khan, R. S. et al. Targeting extracellular DNA to deliver IGF-1 to the injured heart. Sci. Rep. 4, 4257 (2014).","journal-title":"Sci. Rep."},{"key":"BFnpjregenmed20161_CR28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/jgm.1189","volume":"10","author":"M Konishi","year":"2008","unstructured":"Konishi, M., Kawamoto, K., Izumikawa, M., Kuriyama, H. & Yamashita, T. Gene transfer into guinea pig cochlea using adeno-associated virus vectors. J. Gene Med. 10, 610\u2013618 (2008).","journal-title":"J. Gene Med."},{"key":"BFnpjregenmed20161_CR29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/jgm.665","volume":"7","author":"BK Kaspar","year":"2005","unstructured":"Kaspar, B. K. et al. Myocardial gene transfer and long-term expression following intracoronary delivery of adeno-associated virus. J. Gene Med. 7, 316\u2013324 (2005).","journal-title":"J. Gene Med."},{"key":"BFnpjregenmed20161_CR30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cardiores.2005.12.017","volume":"70","author":"OJ M\u00fcller","year":"2006","unstructured":"M\u00fcller, O. J. et al. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. Cardiovasc. Res. 70, 70\u201378 (2006).","journal-title":"Cardiovasc. Res."},{"key":"BFnpjregenmed20161_CR31","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1161\/CIRCRESAHA.114.302331","volume":"114","author":"S Zacchigna","year":"2014","unstructured":"Zacchigna, S., Zentilin, L. & Giacca, M. Adeno-associated virus vectors as therapeutic and investigational tools in the cardiovascular system. Circ. Res. 114, 1827\u20131846 (2014).","journal-title":"Circ. Res."},{"key":"BFnpjregenmed20161_CR32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.12998\/wjcc.v3.i2.112","volume":"3","author":"OF Chacon-Camacho","year":"2015","unstructured":"Chacon-Camacho, O. F. Review and update on the molecular basis of Leber congenital amaurosis. World J. Clin. Cases 3, 112 (2015).","journal-title":"World J. Clin. Cases"},{"key":"BFnpjregenmed20161_CR33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1089\/hgtb.2012.105","volume":"23","author":"H Fang","year":"2013","unstructured":"Fang, H. et al. Comparison of adeno-associated virus serotypes and delivery for cardiac gene transfer. Hum. Gene Ther. Methods 23, 234\u2013241 (2013).","journal-title":"Hum. Gene Ther. Methods"},{"key":"BFnpjregenmed20161_CR34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/apha.12340","volume":"212","author":"P-W Cheng","year":"2014","unstructured":"Cheng, P.-W. et al. Involvement of two distinct signalling pathways in IGF-1-mediated central control of hypotensive effects in normotensive and hypertensive rats. Acta Physiol. 212, 28\u201338 (2014).","journal-title":"Acta Physiol."},{"key":"BFnpjregenmed20161_CR35","first-page":"193","volume":"51","author":"GT Kovacs","year":"1999","unstructured":"Kovacs, G. T. et al. Hypoglycemic effects of insulin-like growth factor-1 in experimental uremia: Can concomitant growth hormone administration prevent this effect? Horm. Res. 51, 193\u2013200 (1999).","journal-title":"Horm. Res."},{"key":"BFnpjregenmed20161_CR36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0305-0491(98)10106-2","volume":"121","author":"AA Butler","year":"1998","unstructured":"Butler, A. A. et al. Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 121, p 19\u201326 (1998).","journal-title":"Comp. Biochem. Physiol. B Biochem. Mol. Biol."},{"key":"BFnpjregenmed20161_CR37","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1074\/jbc.272.10.6653","volume":"272","author":"SA Coolican","year":"1997","unstructured":"Coolican, S. A., Samuel, D. S., Ewton, D. Z., McWade, F. J. & Florini, J. R. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272, 6653\u20136662 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnpjregenmed20161_CR38","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.101.6.660","volume":"101","author":"Y Fujio","year":"2000","unstructured":"Fujio, Y., Nguyen, T., Wencker, D., Kitsis, R. N. & Walsh, K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 101, 660\u2013667 (2000).","journal-title":"Circulation"},{"key":"BFnpjregenmed20161_CR39","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ncb1101-1009","volume":"3","author":"C Rommel","year":"2001","unstructured":"Rommel, C. et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K\/Akt\/mTOR and PI(3)K\/Akt\/GSK3 pathways. Nat. Cell Biol. 3, 1009\u20131013 (2001).","journal-title":"Nat. Cell Biol."},{"key":"BFnpjregenmed20161_CR40","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1083\/jcb.200704179","volume":"179","author":"E Lara-Pezzi","year":"2007","unstructured":"Lara-Pezzi, E. et al. A naturally occurring calcineurin variant inhibits FoxO activity and enhances skeletal muscle regeneration. J. Cell Biol. 179, 1205\u20131218 (2007).","journal-title":"J. Cell Biol."},{"key":"BFnpjregenmed20161_CR41","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/cvr\/cvu068","volume":"102","author":"MM L\u00f3pez-Ola\u00f1eta","year":"2014","unstructured":"L\u00f3pez-Ola\u00f1eta, M. M. et al. Induction of the calcineurin variant CnA\u03b21 after myocardial infarction reduces post-infarction ventricular remodelling by promoting infarct vascularization. Cardiovasc. Res. 102, 396\u2013406 (2014).","journal-title":"Cardiovasc. Res."},{"key":"BFnpjregenmed20161_CR42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bbrc.2011.05.081","volume":"410","author":"MP Santini","year":"2011","unstructured":"Santini, M. P. et al. IGF-1Ea induces vessel formation after injury and mediates bone marrow and heart cross-talk through the expression of specific cytokines. Biochem. Biophys. Res. Commun. 410, 201\u2013207 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnpjregenmed20161_CR43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ymthe.2005.08.017","volume":"13","author":"G Gao","year":"2006","unstructured":"Gao, G. et al. Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates. Mol. Ther. 13, 77\u201387 (2006).","journal-title":"Mol. Ther."},{"key":"BFnpjregenmed20161_CR44","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang, R. M. et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography\u2019s guidelines and standards committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiograph. J. Am. Soc. Echocardiogr. 18, 1440\u20131463 (2005).","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"BFnpjregenmed20161_CR45","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1152\/japplphysiol.00033.2007","volume":"102","author":"J Takagawa","year":"2007","unstructured":"Takagawa, J. et al. Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J. Appl. Physiol. 102, 2104\u20132111 (2007).","journal-title":"J. Appl. Physiol."},{"key":"BFnpjregenmed20161_CR46","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/gkp045","volume":"37","author":"JM Ruijter","year":"2009","unstructured":"Ruijter, J. M. et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 37, e45 (2009).","journal-title":"Nucleic Acids Res."},{"key":"BFnpjregenmed20161_CR47","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1074\/jbc.M113.518951","volume":"289","author":"CD Blackstock","year":"2014","unstructured":"Blackstock, C. D. et al. Insulin-like growth factor-1 increases synthesis of collagen type I via induction of the mRNA-binding protein LARP6 expression and binding to the 5\u2019stem-loop of COL1a1 and COL1a2 mRNA. J. Biol. Chem. 289, 7264\u20137274 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFnpjregenmed20161_CR48","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s12265-012-9400-9","volume":"5","author":"KD Panse","year":"2012","unstructured":"Panse, K. D. et al. Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes. J. Cardiovasc. Transl. Res. 5, 814\u2013826 (2012).","journal-title":"J. Cardiovasc. Transl. Res."}],"updated-by":[{"DOI":"10.1038\/npjregenmed.2017.1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T00:00:00Z","timestamp":1508457600000}}],"container-title":["npj Regenerative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/npjregenmed20161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjregenmed20161","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjregenmed20161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T20:55:28Z","timestamp":1748984128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npjregenmed20161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,9]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,8]]}},"alternative-id":["BFnpjregenmed20161"],"URL":"https:\/\/doi.org\/10.1038\/npjregenmed.2016.1","relation":{},"ISSN":["2057-3995"],"issn-type":[{"value":"2057-3995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,9]]},"assertion":[{"value":"16 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16001"}}